EIR AGC Biologics Nov 2020

Christopher Czajka FDA, Kathryn King FDA, Richard Ledwidge FDA$595.00 - Available Now

FDA investigators audited the AGC Biologics - Bothell, WA, United States facility and issued inspectional observation (via FDA 483) on 02 Nov 2020.

Product details

  • Category:
  • Inspection end: 02 Nov 2020
  • Location: Bothell, United States
  • FEI: 3000209996
Add To Cart